| Income statement (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.99B | 15.00B | 16.62B | 15.78B | 15.42B | 13.34B | 15.10B | 14.46B |
| Cost of revenue | 4.29B | 4.22B | 4.55B | 5.30B | 4.35B | 4.00B | 4.40B | 4.21B |
| Gross profit | 12.70B | 10.78B | 12.07B | 10.47B | 11.08B | 9.34B | 10.71B | 10.25B |
| Research and development | 2.34B | 2.47B | 2.58B | 2.32B | 2.13B | 2.07B | 6.77B | 2.13B |
| Selling, general and admin | 3.63B | 3.58B | 3.90B | 3.57B | 3.25B | 3.29B | 3.85B | 4.21B |
| Operating expenses | 10.56B | 11.01B | 12.07B | 13.87B | 10.53B | 9.61B | 16.59B | 10.63B |
| Operating income | 6.43B | 3.99B | 4.54B | 1.90B | 4.89B | 3.73B | -1.49B | 3.83B |
| EBITDA | 6.63B | 4.18B | 4.75B | 2.10B | 5.08B | 3.91B | -1.28B | 4.02B |
| Interest expense | 746.00M | 717.00M | 714.00M | 739.00M | 740.00M | 700.00M | 702.00M | 720.00M |
| Income before tax | 4.28B | 1.04B | 2.67B | 714.00M | 1.55B | 1.66B | -2.27B | 2.08B |
| Income tax | 662.00M | 342.00M | 853.00M | 526.00M | 613.00M | 372.00M | -2.25B | 520.00M |
| Net income | 3.61B | 695.00M | 1.82B | 186.00M | 938.00M | 1.29B | -22.00M | 1.56B |
| EPS | 2.04 | 0.39 | 1.02 | 0.10 | 0.52 | 0.72 | -0.02 | 0.88 |
| EPS (diluted) | 2.03 | 0.39 | 1.02 | 0.10 | 0.52 | 0.72 | -0.02 | 0.88 |
| Diluted shares | 1.77B | 1.77B | 1.00M | 1.77B | 1.77B | 1.77B | 1.00M | 1.77B |
| Dividends per share | 1.73 | 1.73 | 1.73 | 1.64 | 1.64 | 1.64 | 1.64 | 1.55 |
From AbbVie's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.